Amezalpat received fast track designation from the FDA for the treatment of patients with hepatocellular carcinoma.

Unresectable canine hepatocellular carcinoma (HCC) has limited nonsurgical treatment options. Sorafenib is a targeted therapy for unresectable canine HCC. However, there are limited reports on the ...

A new study shows that artificial intelligence (AI) can help doctors make better decisions when treating cancer. However, it also highlights challenges in how doctors and AI work together. The study ...

The Barbara Ann Karmanos Cancer Institute has opened the Karmanos Cancer Institute — Dearborn along Hubbard Drive, just west ...

Fujifilm Middle East and Africa, part of the globally renowned Fujifilm Corporation, participates at Arab Health 2025, taking ...

A new study led by researchers from Moffitt Cancer Center, in collaboration with investigators from the University of ...

Fujifilm Middle East and Africa part of the globally renowned Fujifilm Corporation is participating at Arab Health 2025 ...

An abdominal ultrasound revealed liver cirrhosis ... Upon admission, further examinations confirmed a diagnosis of hepatocellular carcinoma, which was specifically moderately differentiated (Stage IVA ...

Safety, efficacy, and outcomes of 90-yttrium radioembolization in combination with immune checkpoint inhibitors as a definitive first-line treatment approach in non-surgical hepatocellular carcinoma.

This valuable study investigated the role of PLECTIN, a cytoskeletal crosslinker protein, in hepatocellular carcinoma development and progression. Using a liver-specific Plectin knockout mouse model, ...